Orgenesis Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Orgenesis Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2010 to Q3 2024.
  • Orgenesis Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $32K, a 91.9% decline year-over-year.
  • Orgenesis Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$88K, a 111% decline year-over-year.
  • Orgenesis Inc. annual Income Tax Expense (Benefit) for 2023 was $473K, a 126% increase from 2022.
  • Orgenesis Inc. annual Income Tax Expense (Benefit) for 2022 was $209K, a 93.5% increase from 2021.
  • Orgenesis Inc. annual Income Tax Expense (Benefit) for 2021 was $108K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$88K $32K -$362K -91.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $274K $5K -$86K -94.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $360K $16K -$113K -87.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $473K -$141K -$313K -182% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 $786K $394K +$369K +1476% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $417K $91K +$80K +727% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $337K $129K +$128K +12800% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 $209K $172K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-15
Q3 2022 $25K -$42K -62.7% Jul 1, 2022 Sep 30, 2022 10-Q/A 2024-04-15
Q2 2022 $11K Apr 1, 2022 Jun 30, 2022 10-Q/A 2024-04-15
Q1 2022 $1K +$3K Jan 1, 2022 Mar 31, 2022 10-Q/A 2024-04-15
Q3 2021 $67K +$49K +272% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q1 2021 -$1.66M -$2K -$49K -104% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$1.61M -$1.66M -$1.88M -873% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $268K $18K -$26K -59.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $294K -$12K -$31K -163% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $325K $47K +$96K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $229K $215K +$558K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 -$329K $44K -$2.31M -98.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.98M $19K +$296K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.68M -$49K +$347K +87.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $1.34M -$343K +$1.46M +81% Sep 1, 2018 Nov 30, 2018 10-K 2020-03-09
Q3 2018 -$123K $2.35M +$1.93M +459% Jun 1, 2018 Aug 31, 2018 10-Q 2019-11-07
Q2 2018 -$2.06M -$277K +$167K +37.6% Mar 1, 2018 May 31, 2018 10-Q 2019-08-08
Q1 2018 -$2.22M -$396K -$912K -177% Dec 1, 2017 Feb 28, 2018 10-Q 2019-05-08
Q4 2017 -$1.31M -$1.8M -$1.57M -674% Sep 1, 2017 Nov 30, 2017 10-K 2019-02-13
Q3 2017 $260K $421K +$793K Jun 1, 2017 Aug 31, 2017 10-Q 2018-10-12
Q2 2017 -$533K -$444K +$190K +30% Mar 1, 2017 May 31, 2017 10-Q 2018-07-17
Q1 2017 -$723K $516K +$824K Dec 1, 2016 Feb 28, 2017 10-Q 2018-04-16
Q4 2016 -$1.55M -$233K +$667K +74.1% Sep 1, 2016 Nov 30, 2016 10-K 2018-02-28
Q3 2016 -$2.21M -$372K -$372K Jun 1, 2016 Aug 31, 2016 10-Q 2017-10-16
Q2 2016 -$1.84M -$634K -$634K Mar 1, 2016 May 31, 2016 10-Q 2017-07-24
Q1 2016 -$1.21M -$308K -$308K Dec 1, 2015 Feb 29, 2016 10-Q 2017-04-19
Q4 2015 -$900K -$900K Sep 1, 2015 Nov 30, 2015 10-K 2017-02-28
Q3 2015 -$93* -$93 Jun 1, 2015 Aug 31, 2015 10-Q 2016-10-14
Q2 2015 -$15* -$15 Mar 1, 2015 May 31, 2015 10-Q 2016-07-15
Q1 2015 $0 Nov 29, 2014 Feb 28, 2015 10-Q 2016-04-14
Q3 2014 $0 Jun 1, 2014 Aug 31, 2014 10-Q 2015-10-15
Q2 2014 $0 Mar 1, 2014 May 31, 2014 10-Q 2015-07-15
Q3 2011 $0 $0 Jun 1, 2011 Aug 31, 2011 10-Q/A 2011-11-14
Q3 2010 $0 Jun 1, 2010 Aug 31, 2010 10-Q/A 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.